USE OF HISTONE DEACETYLASE INHIBITORS FOR THE CARE OF PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE SYNDROMES

USE OF HISTONE DEACETYLASE INHIBITORS FOR THE CARE OF PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE SYNDROMES

The use of substances capable of inhibiting one or more enzymes of the histone deacetylase family (histone deacetylase inhibitors) for the therapeutic treatment of Philadelphia-negative myeloproliferative syndromes (polycythemia vera, essential thrombocythemia or idiopathic myelofibrosis) is describ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: RAMBALDI, ALESSANDRO, MASCAGNI, PAOLO, BARBUI, TIZIANO, OLDONI, TIZIANO
Format: Patent
Sprache:eng ; fre
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator RAMBALDI, ALESSANDRO
MASCAGNI, PAOLO
BARBUI, TIZIANO
OLDONI, TIZIANO
description The use of substances capable of inhibiting one or more enzymes of the histone deacetylase family (histone deacetylase inhibitors) for the therapeutic treatment of Philadelphia-negative myeloproliferative syndromes (polycythemia vera, essential thrombocythemia or idiopathic myelofibrosis) is described. The dosage of the above-mentioned substances is significantly lower than that normally used for the care of other tumour syndromes and may be from 10 to 150 mg/day/patient.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2738081C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2738081C</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2738081C3</originalsourceid><addsrcrecordid>eNqFyrEKwjAQgOEuDqI-g_cCBbWDXc_0Yg7SXEmi0KkUiTiIFur7Y1F3px8-_nl2OwUC0WA4RHEEFaGi2FqcmJ3hA0fxAbR4iIZAof_sjWGLFdmpmDs6YuQzQd2SlcaLZU3-S6F1lZeawjKbXfv7mFa_LrK1pqhMnoZnl8ahv6RHenUKd_ui3JRbVfw_3mPRNQ0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>USE OF HISTONE DEACETYLASE INHIBITORS FOR THE CARE OF PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE SYNDROMES</title><source>esp@cenet</source><creator>RAMBALDI, ALESSANDRO ; MASCAGNI, PAOLO ; BARBUI, TIZIANO ; OLDONI, TIZIANO</creator><creatorcontrib>RAMBALDI, ALESSANDRO ; MASCAGNI, PAOLO ; BARBUI, TIZIANO ; OLDONI, TIZIANO</creatorcontrib><description>The use of substances capable of inhibiting one or more enzymes of the histone deacetylase family (histone deacetylase inhibitors) for the therapeutic treatment of Philadelphia-negative myeloproliferative syndromes (polycythemia vera, essential thrombocythemia or idiopathic myelofibrosis) is described. The dosage of the above-mentioned substances is significantly lower than that normally used for the care of other tumour syndromes and may be from 10 to 150 mg/day/patient.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20171107&amp;DB=EPODOC&amp;CC=CA&amp;NR=2738081C$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20171107&amp;DB=EPODOC&amp;CC=CA&amp;NR=2738081C$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>RAMBALDI, ALESSANDRO</creatorcontrib><creatorcontrib>MASCAGNI, PAOLO</creatorcontrib><creatorcontrib>BARBUI, TIZIANO</creatorcontrib><creatorcontrib>OLDONI, TIZIANO</creatorcontrib><title>USE OF HISTONE DEACETYLASE INHIBITORS FOR THE CARE OF PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE SYNDROMES</title><description>The use of substances capable of inhibiting one or more enzymes of the histone deacetylase family (histone deacetylase inhibitors) for the therapeutic treatment of Philadelphia-negative myeloproliferative syndromes (polycythemia vera, essential thrombocythemia or idiopathic myelofibrosis) is described. The dosage of the above-mentioned substances is significantly lower than that normally used for the care of other tumour syndromes and may be from 10 to 150 mg/day/patient.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFyrEKwjAQgOEuDqI-g_cCBbWDXc_0Yg7SXEmi0KkUiTiIFur7Y1F3px8-_nl2OwUC0WA4RHEEFaGi2FqcmJ3hA0fxAbR4iIZAof_sjWGLFdmpmDs6YuQzQd2SlcaLZU3-S6F1lZeawjKbXfv7mFa_LrK1pqhMnoZnl8ahv6RHenUKd_ui3JRbVfw_3mPRNQ0</recordid><startdate>20171107</startdate><enddate>20171107</enddate><creator>RAMBALDI, ALESSANDRO</creator><creator>MASCAGNI, PAOLO</creator><creator>BARBUI, TIZIANO</creator><creator>OLDONI, TIZIANO</creator><scope>EVB</scope></search><sort><creationdate>20171107</creationdate><title>USE OF HISTONE DEACETYLASE INHIBITORS FOR THE CARE OF PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE SYNDROMES</title><author>RAMBALDI, ALESSANDRO ; MASCAGNI, PAOLO ; BARBUI, TIZIANO ; OLDONI, TIZIANO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2738081C3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2017</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>RAMBALDI, ALESSANDRO</creatorcontrib><creatorcontrib>MASCAGNI, PAOLO</creatorcontrib><creatorcontrib>BARBUI, TIZIANO</creatorcontrib><creatorcontrib>OLDONI, TIZIANO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>RAMBALDI, ALESSANDRO</au><au>MASCAGNI, PAOLO</au><au>BARBUI, TIZIANO</au><au>OLDONI, TIZIANO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>USE OF HISTONE DEACETYLASE INHIBITORS FOR THE CARE OF PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE SYNDROMES</title><date>2017-11-07</date><risdate>2017</risdate><abstract>The use of substances capable of inhibiting one or more enzymes of the histone deacetylase family (histone deacetylase inhibitors) for the therapeutic treatment of Philadelphia-negative myeloproliferative syndromes (polycythemia vera, essential thrombocythemia or idiopathic myelofibrosis) is described. The dosage of the above-mentioned substances is significantly lower than that normally used for the care of other tumour syndromes and may be from 10 to 150 mg/day/patient.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_CA2738081C
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title USE OF HISTONE DEACETYLASE INHIBITORS FOR THE CARE OF PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE SYNDROMES
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T05%3A57%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=RAMBALDI,%20ALESSANDRO&rft.date=2017-11-07&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2738081C%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true